Description

Evidapa – Dapagliflozin Propanediol Monohydrate Tablets 10 mg

• Exerts antihyperglycemic, cardioprotective and nonprotective properties.
• Reduces renal glucose reabsorption by increasing urinary glucose excretion and reducing blood glucose levels.
• Reduce body weight and blood pressure (BP) across a broad spectrum of patients.
• Reduces SSB and improve glycemic control in patients with inadequately controlled T2D and hypertension.
• Slow the progression of the renal and liver fibrosis associated with type-2 diabetes.